Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
What's New at TheBody.com
  
  • Email Email
  • Glossary Glossary

 

Risks Versus Rewards: Why People With HIV Volunteer for Cure Research

Jennifer Power, The Conversation; Posted Jun 29, 4:20 p.m. ET

As HIV cure research continues to gain momentum, people living with HIV, community advocates and social researchers should work closely with the scientific community on its social and ethical implications, according to Jennifer Power of the Australian Research Centre in Sex, Health and Society.

Obamacare's Next 5 Hurdles to Clear

Julie Appleby, Mary Agnes Carey, Phil Galewitz and Jordan Rau , Kaiser Health News; Posted Jun 29, 3:20 p.m. ET

The ACA has survived technical meltdowns, a presidential election, two Supreme Court challenges and dozens of Congressional repeal efforts. Here are five of the biggest hurdles left.

Study Finds Almost Half of Health Law Plans Offer Very Limited Physician Networks

Michelle Andrews, Kaiser Health News; Posted Jun 29, 3:12 p.m. ET

Kaiser Health News columnist Michelle Andrews writes: "If the physician networks for plans sold on the health law's online insurance exchanges were T-shirts, more than 40 percent would be size X-small or small."

Regaining Our Footing on the Road to an AIDS-Free Generation

Scott Schoettes and Gregory R. Nevins, Lambda Legal; Posted Jun 29, 2:01 p.m. ET

Even as we celebrate the Supreme Court's decision in King v. Burwell, much work remains to be done on the road to access to quality care for all and an end to AIDS in this country, reminds Lambda Legal. At the top of the priority list remains expansion of Medicaid in the 22 states that have not yet opted to expand the program.

Share Your Stories!

Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.

Day One With HIV: Finding Out Your Status, in Your Own Words

Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?


Other Sides of HIV: People Taking HIV Meds Share Stories About Side Effects

Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?

 

Do Geriatric Conditions Occur Early in HIV-Positive Men?

Mathew Rodriguez, TheBody.com; Posted Jun 29, 1:45 p.m. ET

Gay men may face a host of aging-related conditions in middle age as opposed to old age. New research can tell you what you should get screened for to keep your body in top shape.

Adolescents at Increased Risk of Vertical Transmission and Poor Pregnancy Outcome in South Africa

Polly Clayden, HIV i-Base; Posted Jun 29, 1:38 p.m. ET

Adolescent pregnant women had an increased risk of vertical transmission of HIV and poorer maternal and infant outcomes, compared to non-adolescent women, in a high HIV prevalence district in South Africa.

Pregnancy Rates Among Women Using Antiretroviral Therapy and Hormonal Contraceptives in Kenya

Polly Clayden, HIV i-Base; Posted Jun 29, 1:05 p.m. ET

Incident pregnancy rates in HIV-positive women using the subdermal hormonal implant with efavirenz-based antiretroviral therapy were 2.6 times higher than in women using nevirapine-based antiretroviral therapy, according to a study conducted in Western Kenya.

On TheBodyPRO.com: IL-21 May Play Key Role in Limiting Early HIV Infection

Mark Mascolini, TheBodyPRO.com; Posted Jun 26, 5:44 p.m. ET

A protein known as interleukin-21 appears to have the ability to limit the amount of HIV replication that takes place soon after a person is infected, researchers have found. The findings may have implications for both HIV treatment and prevention.

My Health Tracker

My Health Tracker

My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.

Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.

 

When Tummy Troubles Strike, Should You Treat at Home or Call Your Provider?

Martha Kempner, TheBody.com; Posted Jun 26, 3:23 p.m. ET

Stomach woes are an annoying fact of life. When should you just manage them on your own, and when should you seek help? We asked doctors to help our readers figure out when to hit the drug store for the pink stuff and when to call their health care provider instead.

This Week in HIV Research: The Early Treatment Bandwagon; New U.S. Surveillance Data; Hep C Treatment Cost Effectiveness; and More

Myles Helfand, TheBodyPRO.com; Posted Jun 26, 2:51 p.m. ET

This week, the United Kingdom took a big step toward universal HIV treatment, one of the most visually engaging HIV surveillance tools in the U.S. got an update, and we learned something new about the cost of hepatitis C treatment and the importance of nutrition, among other noteworthy developments.

My HIV Doctor Appointments, My Favorite Days of the Year

Anthony Romano , TheBody.com; Posted Jun 24, 8:57 p.m. ET

Christmas used to be Anthony's favorite day of the year, but now his favorite day is when he gets to be with his doctor, who he says changed him for the better.

Pharmacokinetics in Pregnancy: Darunavir/Ritonavir and Etravirine

Polly Clayden, HIV i-Base; Posted Jun 24, 8:43 p.m. ET

Two small studies presented at the 5th International Workshop on HIV & Women evaluated the pharmacokinetics of darunavir/ritonavir (DRV/r) and etravirine (ETV) respectively in pregnancy. In both studies drug exposure was altered -- lower for DRV and higher for ETV.


>> Browse Older Featured Stories

 


  
  • Email Email
  • Glossary Glossary
Advertisement